《ADA和ENDO聯(lián)合發(fā)布低血糖和糖尿病共識(shí)報(bào)告》內(nèi)容簡(jiǎn)介：

    To review the evidence about the impact of hypoglycemia on patients withdiabetes that has become available since the past reviews of this subject by the American DiabetesAssociation and The Endocrine Society and to provide guidance about how this new ***rmationshould be incorporated into clinical practice.

    《ADA和ENDO聯(lián)合發(fā)布低血糖和糖尿病共識(shí)報(bào)告》內(nèi)容預(yù)覽：

    1） Severe hypoglycemia. Severe hypo-glycemia is an event requiring assistanceof another person to actively administercarbohydrates, glucagon, or take othercorrective actions. Plasma glucose con-centrations may not be available duringan event, but neurological recovery fol-lowing the return of plasma glucose tonormal is considered suf cient evidencethat the event was induced by a lowplasma glucose concentration.

    2） Documented symptomatic hypogly-cemia. Documented symptomatic hypo-glycemia is an event during which typicalsymptoms of hypoglycemia are accompa-nied by a measured plasma glucose con-centration #70 mg/dL （#3.9 mmol/L）。

    3） Asymptomatic hypoglycemia. Asymp-tomatic hypoglycemia is an event notaccompanied by typical symptoms of hy-poglycemia but with a measured plasmaglucose concentration #70 mg/dL （#3.9mmol/L）。

    4） Probable symptomatic hypoglyce-mia. Probable symptomatic hypoglycemiais an event during which symptoms typicalof hypoglycemia are not accompanied by aplasma glucose determination but that waspresumably caused by a plasma glucoseconcentration #70 mg/dL （#3.9 mmol/L）。

    點(diǎn)擊下載***：《ADA和ENDO聯(lián)合發(fā)布低血糖和糖尿病共識(shí)報(bào)告》